Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein

J Clin Invest. 1991 Aug;88(2):553-60. doi: 10.1172/JCI115339.

Abstract

Endogenous apolipoprotein E in VLDL is poorly expressed in receptor binding processes. Yet catabolism of VLDL-remnants by cellular receptors depends on functional apo E molecules. To better understand remnant catabolism phenomena, we determined the metabolism of VLDL and post-lipolysis VLDL by cultured cells. Partial lipolysis was achieved by incubation of VLDL with lipoprotein lipase in vitro (human) or recirculation (rat) in supradiaphragmatic animals. Lipolyzed VLDL exhibit metabolic activities 2-20-fold higher than control VLDL, that are saturable and dependent on the presence of LDL receptors. The ligand responsible for receptor interaction of lipolyzed VLDL (apo E or apo B-100) and its source (endogenous or transferred) was studied with monoclonal antibodies and with lipoproteins from E-3/3 and E-2/2 subjects. The data unequivocally proved that lipolysis causes exposure of unreactive endogenous apo E-3 at the VLDL surface, possibly by a change of conformation of the protein. Apo B-100 becomes biologically expressed only in lipolyzed VLDL-III. Lipolyzed VLDL, however, is less reactive to exogenous apo E-3 than control VLDL indicating that endogenous and exogenous apo E are oriented differently in VLDL. It is proposed that VLDL delivers triglycerides to tissues when apo E is unreactive but becomes a remnant after the protein becomes exposed and directs the particles from lipoprotein lipase sites to cellular receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoprotein B-100
  • Apolipoprotein E3
  • Apolipoproteins B / metabolism
  • Apolipoproteins E / metabolism*
  • Biological Transport
  • Fibroblasts / metabolism
  • Humans
  • Lipolysis*
  • Lipoproteins, VLDL / blood*
  • Male
  • Rats
  • Receptors, LDL / metabolism
  • Triglycerides / metabolism

Substances

  • Apolipoprotein B-100
  • Apolipoprotein E3
  • Apolipoproteins B
  • Apolipoproteins E
  • Lipoproteins, VLDL
  • Receptors, LDL
  • Triglycerides